GelStat Corporation
GSAC - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.23M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.23 Million |
|---|---|
| Enterprise Value | $2.07 Million |
| Earnings per Share | $0 |
| Beta | 1.64 |
| Outstanding Shares | 3,065,434,945 |
Return
| Return on Equity | 23.15% |
|---|---|
| Return on Assets | -87.03% |
| Return on Invested Capital | 44.69% |
Valuation & Multiples
| P/E Ratio | -2.81 |
|---|---|
| PEG | -2.34 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 5.45 |
| Enterprise Value to EBIT | -11.02 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.41 |
| Debt to Equity | -0.71 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About GelStat Corporation
2 employees
CEO: Javier G. Acosta
GelStat Corporation operates as a consumer healthcare enterprise, specializing in the innovation, formulation, and commercialization of over-the-counter (OTC) and other non-prescription health solutions. Its diverse product portfolio add...